Replies to post #64300 on $heff's $tation of $tocks & $olid DD

[Wrinkles]

IPCI - Intellipharmaceutics' goals for 2013 include the following:

-- Obtain FDA approval of our generic version of Focalin XR(R)

-- Obtain FDA approval of one or more additional ANDAs

-- File up to two additional ANDAs with the FDA

-- Establish one or more additional development/marketing alliances

-- Complete Phase I studies of Rexista(TM)oxycodone

-- Complete additional Phase I studies of controlled-release pregabalin
--------------------------------------------------------------
(link back for rest of the PR....)